MedPath

A study on Panchathaarai kuzhambu(internal medicine) and ottrai thalaivali thylam (external medicine)in the management of ottrai thalaivali(migraine)

Phase 3
Conditions
Health Condition 1: G439- Migraine, unspecified
Registration Number
CTRI/2023/02/049693
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Five migraine attacks, in the last 3 months each lasting for 4-72 hours and having any

two of the following characteristics,

a) Headache of unilateral location,

b) Pulsating quality,

c) Mild to moderate intensity

d) Aggravation by routine physical activity.

Patient must have at least any one of the following symptoms,

a) Often accompanied by nausea (and/or vomiting).

b) Sensitivity to light and sound.

â?ª Headache Impact Test total score range 36-59 will be included

â?ª Patient who is willing to participate in the study by signing consent and fulfilling the

conditions of Proforma.

Exclusion Criteria

Cervical spondylosis

Cerebro vascular diseases

Trigeminal neuralgia.

Traumatic history

Psychiatric illness

Seizures

Alcoholism

Pregnancy

Sinusitis headaches

Ear disorders

Eye diseases

Diabetes mellitus

Hypertension

Patient with any other serious systemic diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Headache Impact Test <br/ ><br>score will be assessed before and after treatmentTimepoint: 2 MONTHS- SCREENING <br/ ><br>2 MONTHS- PATIENT ENROLLMENT <br/ ><br>2 MONTHS- OUTCOME ASSESSMENT
Secondary Outcome Measures
NameTimeMethod
Changes in headache frequency, duration of headache, preceding symptoms, <br/ ><br>nature of headache, assosiated symptoms, suspected triggers and relieving factors <br/ ><br>through Headache diary will be assessed before and after treatmentTimepoint: 2 MONTHS- SCREENING <br/ ><br>2 MONTHS- PATIENT ENROLLMENT <br/ ><br>2 MONTHS- OUTCOME ASSESSMENT
© Copyright 2025. All Rights Reserved by MedPath